文献速递贫血与红细胞疾病

重型再生障碍性贫血患者SLAMF6表达的初步研究

[A preliminary study on SLAMF6 expression in patients with severe aplastic anemia].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2018-01-01

该研究采用流式细胞术检测21例初治重型再生障碍性贫血(SAA)患者及15例正常对照外周血CD8(+) T细胞SLAMF6表达量,并分析其与造血功能指标及CD8(+) T细胞功能分子的相关性。结果显示SAA患者SLAMF6表达明显低于正常对照,且与造血指标正相关、与穿孔素、颗粒酶B、IFN-γ负相关;阻断SLAMF6后上述功能分子分泌增多。结论提示SLAMF6可能作为负性免疫调节分子参与SAA机制。

要点

  • 初治SAA患者CD8(+) T细胞SLAMF6表达量低于正常对照。
  • SLAMF6表达与HGB、PLT、中性粒细胞绝对值、网织红细胞绝对值正相关。
  • SLAMF6表达与CD8(+) T细胞穿孔素、颗粒酶B、IFN-γ表达量负相关。

核心结论

  • SLAMF6在SAA患者CD8(+) T细胞中明显低表达,可能作为负性免疫调节分子通过影响CD8(+) T细胞功能分子分泌参与SAA发生机制。

研究设计与样本

  • 研究纳入2017年2月至2018年4月天津医科大学总医院血液科收治的初治SAA患者21例,以15例健康人外周血标本作为正常对照。
  • 采用流式细胞术检测外周血CD8(+) T细胞SLAMF6表达量,并与临床指标及CD8(+) T细胞功能分子进行相关性分析。
  • 进一步采用anti-SLAMF6 Ab阻断SLAMF6功能,以IgG作为对照,流式细胞术检测CD8(+) T细胞穿孔素、颗粒酶B、IFN-γ分泌量。

主要发现

  • 初治SAA患者CD8(+) T细胞SLAMF6表达量为(56.29±12.97)%,正常对照为(80.96±7.36)%,SAA患者低于正常对照(t=-7.672,P<0.001)。
  • 初治SAA患者CD8(+) T细胞SLAMF6表达量与HGB、PLT、中性粒细胞绝对值、网织红细胞绝对值、骨髓粒系百分比、骨髓红系百分比均呈正相关(P<0.05)。
  • 初治SAA患者CD8(+) T细胞SLAMF6表达量与骨髓淋系百分比及CD8(+) T细胞穿孔素、颗粒酶B、IFN-γ表达量均呈负相关(P<0.05)。
  • anti-SLAMF6 Ab阻断SLAMF6后,初治SAA患者CD8(+) T细胞anti-SLAMF6 Ab处理组穿孔素、颗粒酶B、IFN-γ表达量较未处理组明显增多(P值均<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the expression of SLAMF6 on CD8(+) T cells in patients with severe aplastic anemia (SAA) and its correlation with disease immune status. Methods: By flow cytometry (FCM), SLAMF6 expression level in peripheral blood CD8(+) T cells was detected in 21 patients with SAA and 15 normal controls respectively from February 2017 to April 2018. The correlation between SLAMF6 expression level and hematopoietic functions, including HGB, PLT, the neutrophil granulocyte and reticulocyte absolute value in peripheral blood, hyperplasia degree (percentage of granulocytes, erythrocytes, lymphocytes and megakaryocytes in bone marrow) and perforin, granzyme B, IFN-γ expression level in CD8(+) T cells were evaluated. To further confirm the effect of SLAMF6 on CD8(+) T cells, anti-SLAMF6 Ab was used to block SLAMF6 pathway (IgG as control), and FCM was used to detect the perforin, granzyme B, and IFN-γ production of CD8(+) T cells. Results: The expression of SLAMF6 on CD8(+) T cells in untreated SAA patients[(56.29±12.97)%]was significantly lower than that of normal controls[(80.96±7.36)%](t=-7.672, P<0.001). The expression of SLAMF6 on CD8(+) T cells in SAA patients were positively correlated with the HGB, PLT, the neutrophil granulocyte and reticulocyte absolute value in peripheral blood, percentage of granulocytes, erythrocytes in bone marrow (all P<0.05), but they were negatively correlated with the percentage of lymphocytes in bone marrow, and the expression of perforin, granzyme B, and IFN-γ of CD8(+) T cells (all P<0.05). After blocking SLAMF6 pathway by anti-SLAMF6 Ab, the expression levels of perforin, granzyme B and IFN-γ in SAA patients were significantly higher than those in the untreated group, and the differences were statistically significant (all P<0.05). Conclusions: SLAMF6 is significantly down-regulated on CD8(+) T cells in SAA patients, which may act as a negative immunoregulatory molecule participating in the mechanism of SAA by affecting the functional molecules secretion on CD8(+) T cells. 目的: 探讨SLAMF6在重型再生障碍性贫血(SAA)CD8(+) T细胞中的表达情况及其与疾病免疫状态的相关性。 方法: 选取2017年2月至2018年4月天津医科大学总医院血液科收治的初治SAA患者21例,以15例健康人外周血标本作为正常对照,应用流式细胞术(FCM)检测外周血CD8(+) T细胞SLAMF6表达量,并与患者HGB、PLT、中性粒细胞绝对值、网织红细胞绝对值、骨髓造血功能(粒系百分比、红系百分比、淋系百分比、巨核细胞数)等临床指标及CD8(+) T细胞功能分子穿孔素、颗粒酶B、IFN-γ表达量进行相关性分析。进一步采用anti-SLAMF6 Ab阻断其功能,FCM检测CD8(+) T细胞穿孔素、颗粒酶B、IFN-γ分泌量。 结果: 初治SAA患者CD8(+) T细胞SLAMF6表达量明显低于正常对照,差异有统计学意义[(56.29±12.97)%对(80.96±7.36)%,t=-7.672,P<0.001];初治SAA患者CD8(+) T细胞SLAMF6表达量与HGB、PLT、中性粒细胞绝对值、网织红细胞绝对值、骨髓粒系百分比、骨髓红系百分比均呈正相关(P<0.05),与CD8(+) T细胞穿孔素、颗粒酶B、IFN-γ表达量均呈负相关(P<0.05);anti-SLAMF6 Ab阻断该信号分子后,初治SAA患者CD8(+) T细胞anti-SLAMF6 Ab处理组穿孔素、颗粒酶B、IFN-γ表达量较未处理组明显增多,差异有统计学意义(P值均<0.05)。 结论: SLAMF6在SAA患者CD8(+) T细胞中明显低表达,其可能作为负性免疫调节分子通过影响CD8(+) T细胞功能分子的分泌参与SAA的发生机制。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zeng LJ, Liu CY, Ding SX, et al. [A preliminary study on SLAMF6 expression in patients with severe aplastic anemia]. Zhonghua Xue Ye Xue Za Zhi. 2018. PMID: 30486590. doi:10.3760/cma.j.issn.0253-2727.2018.11.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。